Autres langues ARCA biopharma, Inc.

Actions

ABIO

US00211Y5069

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 14/06/2024			Varia. 5j.	Varia. 1 janv.
3,31 ^USD	-0,30 %		+0,91 %	+94,71 %

25/04	ARCA biopharma, Inc. déclare ses résultats pour le premier trimestre clos le 31 mars 2024	CI
04/04	ARCA biopharma, Inc. annonce des changements au sein de sa direction	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka	05/06
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	11/05
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	25/04
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
North American Morning Briefing : Stock Futures -2-	19/04
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	10/04
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	05/04
ARCA biopharma, Inc. Announces Management Changes	04/04
ARCA biopharma, Inc. Announces Separation of Michael Bristow, Chief Executive Officer	04/04
Sector Update: Health Care Stocks Softer Late Afternoon	03/04
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	03/04
Top Midday Gainers	03/04
Sector Update: Health Care Stocks Rise Wednesday Afternoon	03/04
Sector Update: Health Care	03/04
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge	03/04
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	03/04
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	03/04
Oruka Therapeutics announced that it expects to receive $275 million in funding	03/04
ARCA biopharma Announces 2023 Financial Results	01/02
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ARCA biopharma, Inc.

Actions

ABIO

US00211Y5069

Autres langues

Filtres